JACOBIO-B 01167Hong Kong Stock Exchange

5.5704.30%( -0.250 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
JACOBIO-B (01167) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-12-21
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG4987A1094

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)62.77M94/112
Net Profit (Last FY)-171.19M72/125
ROE (Last FY)-18.94%78/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Yinxiang WANG Executive Director
Xiaojie WANG Executive Director
Yunyan HU Executive Director
Te-li CHEN Non-Executive Director
Ruilin SONG Independent Non-Executive Director
Ge WU Independent Non-Executive Director
Bai LU Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-03-19.

About this page

This page shows JACOBIO-B (01167) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.